MAIA BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.75 USD | +8.20% |
|
+27.01% | +305.98% |
| 05-21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
| 05-14 | MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar MAIA Biotechnology, Inc.
46ca4077cc6539363148309660b7a.PPxPb-mRqfhkmArD5AU5Xsc17EFckW3TcAfCbDJ475I.TpQHPbvhnqkI6GP3lXVQDKl3qRAz2x-wBGOXLWRMh6NMuw4Bq6DGshLHWw~894f623bb23fe2a0b24fa26f270c5223
Upcoming events on MAIA Biotechnology, Inc.
Past events on MAIA Biotechnology, Inc.
| 24/05/2024 16:00 | Annual General Meeting |
| 14/05/2024 | EF Hutton Investor Conference |
| 05/05/2024 | Q1 2024 Earnings Release (Projected) |
| 17/04/2024 16:00 | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 09/04/2024 21:30 | LD Micro Invitational Conference |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No: 5108 |
| 17/03/2024 | Roth Conference |
| 09/01/2024 19:30 | Biotech Showcase |
| 07/11/2023 13:15 | Q3 2023 Earnings Release |
| 29/10/2023 | Turkish Biochemical Society International Biochemistry Congress |
| 22/10/2023 | European Society for Medical Oncology Congress - Presentation No 1493P |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 08/08/2023 13:00 | Q2 2023 Earnings Release |
| 25/05/2023 16:00 | Annual General Meeting |
| 08/05/2023 13:00 | Q1 2023 Earnings Release |
| 26/04/2023 18:30 | Planet MicroCap Showcase |
| 17/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract Number: CT050 / 8 |
| 24/03/2023 20:30 | Q4 2022 Earnings Release |
| 05/02/2023 | BIO CEO and Investor Conference |
| 19/01/2023 18:00 | Sidoti Micro-Cap Virtual Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -16,2 -15,1 -7.08% | -20,2 -19,5 -3.71% | -29,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -16,2 -14,9 -8.46% | -20,2 -21,3 5.07% | -33,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -15,8 -15,5 -1.52% | -19,8 -21,2 6.72% | -33,5 |
|
Net income Million USD | Released Forecast Spread | -12,5 | -16,2 -15,5 -4.42% | -19,8 -21,2 6.72% | -33,5 |
|
EPS USD | Released Forecast Spread | -2,37 | -1,75 -1,81 3.05% | -1,49 -1,50 0.33% | -1,59 |
| Announcement Date | 11/04/22 | 24/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,29 -4,30 -23.12% | -4,18 -4,75 11.91% | -4,66 -5,50 15.19% | -4,96 -6,20 20.07% | -6,38 -7,00 8.89% | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,12 -4,23 -21.06% | -4,12 -4,76 13.42% | -4,52 -5,51 17.83% | -4,88 -6,21 21.42% | -6,26 -7,01 10.68% | |||||
|
Net income Million USD | Released Forecast Spread | -5,57 -4,23 -31.72% | -4,12 -4,76 13.42% | -4,52 -5,51 17.83% | -4,88 -6,21 21.42% | -6,26 -7,01 10.68% | |||||
|
EPS USD | Released Forecast Spread | -0,48 -0,49 2.04% | -0,35 -0,42 15.66% | -0,38 -0,40 5% | -0,35 -0,38 7.89% | -0,36 -0,39 6.49% | -0,41 -0,39 -5.13% | -0,46 -0,39 -17.95% | -0,42 | -0,40 | -0,39 |
| Announcement Date | 06/02/23 | 24/03/23 | 08/05/23 | 08/08/23 | 07/11/23 | 21/03/24 | 14/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for MAIA Biotechnology, Inc.
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MAIA Stock
- Calendar MAIA Biotechnology, Inc.
